Also sub-analysis of the COPD group showed no significant differences in Nrf2 or Keap-1 protein expression levels between those patients taking inhaled corticosteroids and/or long-acting bronchodilator treatment versus those without these treatments (Supplement Fig. 7). This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.